Sutro Biopharma, Inc. (S09.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 03:29PM CEST. Market open.
| Previous Close | 3.2200 |
| Open | 3.4200 |
| Bid | 3.6400 x 0 |
| Ask | 3.7800 x 0 |
| Day's Range | 3.4200 - 3.4400 |
| 52 Week Range | 1.9100 - 5.4500 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | 300.588M |
| Beta (5Y Monthly) | 0.98 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?
AnaptysBio (ANAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- Simply Wall St.
Sutro Biopharma, Inc. (NASDAQ:STRO) Analysts Just Cut Their EPS Forecasts Substantially
The analysts covering Sutro Biopharma, Inc. ( NASDAQ:STRO ) delivered a dose of negativity to shareholders today, by...
- GuruFocus.com
Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances
Full Year Earnings Reveal Strong Revenue Growth but Operational Challenges Persist
© 2024 Yahoo. All rights reserved.